'No evidence' that bone-growth agent for spinal fusion increases cancer risk
A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine.
Nov 12, 2015
0
5